Potent new hepatitis C drug: First clinical trials successfully completed

The first clinical trials on a new investigational drug being developed to treat infections caused by hepatitis C virus have been successfully completed. Completion of the initial phase (phase 1a) of trials of INX-189 means the chances of it becoming an approved medicine have significantly improved.

Read the whole article on Science Daily

More from Science Daily